Ads
related to: drug relapse rates- Info for Family & Friends
Learn ways to support your Veteran
in their mental health journey
- Self-Assessments
Feelings and Behavior
related to mental health conditions
- Stress and Anxiety
Improve your well-being
Resources to help you manage
- VA Resource Locator
Explore mental health resources
Take the next step to care
- Info for Family & Friends
Search results
A second animal tranquilizer has infiltrated the state's street drugs, making deadly mark
Detroit Free Press· 10 hours agoLike xylazine before it, the new drug, medetomidine, is a non-opioid animal tranquilizer that is not...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 14 hours agoAll key secondary endpoints (annualized flare rate; flare-free, treatment-free complete remission;...
Immunotherapy drug may help 'cure' advanced colorectal cancer without surgery
MedicalNewsToday via AOL· 17 hours agoGiving the immunotherapy drug pembrolizumab before surgery instead of chemotherapy may help improve...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 3 days agoRong Xu, professor of biomedical informatics and director of CWRU’s centre for artificial intelligence in drug discovery said it was an observational...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 16 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with ...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 23 hours agoOverall survival, complete response or better, very good partial response or better, the rate of...
Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer...
The Woonsocket Call· 5 days agoThe global pivotal WU-KONG1B study investigating sunvozertinib achieved its primary objective with a manageable safety profile in relapsed or refractory NSCLC with EGFR exon20ins ...
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the...
Benzinga· 6 hours agoApproval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast (RS) status Durable and sustained red blood cell transfusion
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 5 days agoAt a median follow-up of 21.8 months, the 12-month estimated PFS rates were 71% with BPd versus 51%...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 7 days agoSquibb (BMS) has received approval from the US Food and Drug Administration for Breyanzi...